Remko Prevo

7.9k citations

34 papers · 5.8k indexed · 2 hit papers · h-index 25

Impact in

Oncology top 0.5%
- Lymphatic System and Diseases
- Cancer Cells and Metastasis
- Vascular Tumors and Angiosarcomas
Molecular Biology top 2%
- Angiogenesis and VEGF in Cancer
- DNA Repair Mechanisms

Papers in

Microbiology 1
Oncology 24
- Lymphatic System and Diseases 12
- PARP inhibition in cancer therapy 5

Co-authors: David G. Jackson Suneale Banerji Steven Clasper Kari Alitalo Michael Detmar Lucia Riccardi Kevin P. Claffey Thomas Hawighorst
Journals: Journal of Biological Chemistry (4 papers)Cell Death and Disease (3 papers)British Journal of Cancer (2 papers)Nature Medicine (2 papers)Cancer Biology & Therapy (2 papers)
Partner nations: United Kingdom United States Finland

In The Last Decade

Remko Prevo

34 papers receiving 5.7k citations

Hit Papers

align trajectories log scale

Induction of tumor lymphangiogenesis by VEGF-C promotes breast cancer metastasis 2001 · 1.4k citations

Peers

Countries citing papers authored by Remko Prevo

Since Specialization

Citations

This map shows the geographic impact of Remko Prevo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Remko Prevo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Remko Prevo more than expected).

Fields of papers citing papers by Remko Prevo

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Remko Prevo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Remko Prevo. The network helps show where Remko Prevo may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Remko Prevo, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Remko Prevo Line = papers co-authored together Remko Prevo links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Antitumour effect of the mitochondrial complex III inhibitor Atovaquone in combination with anti-PD-L1 therapy in mouse cancer models Cell Death and Disease ·Gonzalo Rodríguez‐Berriguete, Rathi Puliyadi, V. Dubenskyy, Alessandro Barberis, Remko Prevo, Martin McLaughlin, Francesca M. Buffa, Kevin J. Harrington, Geoff S. Higgins	2024	13
2	Targeting TOPK sensitises tumour cells to radiation-induced damage by enhancing replication stress Cell Death and Differentiation ·Katharine Herbert, Rathi Puliyadi, Remko Prevo, Gonzalo Rodríguez‐Berriguete, Anderson J. Ryan, Kristijan Ramadan, Geoff S. Higgins	2020	16
3	External Beam Radiation Therapy and Enadenotucirev: Inhibition of the DDR and Mechanisms of Radiation-Mediated Virus Increase Cancers ·Hermann Poschenrie, 谷蕾, Rathi Puliyadi, Remko Prevo, Zhao Zong-ying, Alif Luthvi Azizah, 輝郎大山, Gonzalo Rodríguez‐Berriguete, Kerry D. Fisher, A.F. Olshan, Katharine Herbert, Adella Sari Br Sitepu, Brian Champion, Geoff S. Higgins, Leonard W. Seymour, Janet Lei-Rossmann	2020	15
4	The anti-malarial drug atovaquone potentiates platinum-mediated cancer cell death by increasing oxidative stress Cell Death Discovery ·James T. Coates, Gonzalo Rodríguez‐Berriguete, Rathi Puliyadi, Thomas M. Ashton, Remko Prevo, Nathalie Sierra-Scroccaro, A.F. Olshan, Giacomo Pirovano, Gillies McKenna, Geoff S. Higgins	2020	18
5	CDK1 inhibition sensitizes normal cells to DNA damage in a cell cycle dependent manner Cell Cycle ·Remko Prevo, Giacomo Pirovano, Rathi Puliyadi, Katharine Herbert, Gonzalo Rodríguez‐Berriguete, Thong, W. M. H. Greaves, W. Gillies McKenna, Geoff S. Higgins	2018	54
6	T-LAK cell-originated protein kinase (TOPK): an emerging target for cancer-specific therapeutics Cell Death and Disease ·Katharine Herbert, Thomas M. Ashton, Remko Prevo, Giacomo Pirovano, Geoff S. Higgins	2018	60
7	TOPK modulates tumour-specific radiosensitivity and correlates with recurrence after prostate radiotherapy British Journal of Cancer ·Giacomo Pirovano, Thomas M. Ashton, Katharine Herbert, Richard J. Bryant, Clare Verrill, Lucia Cerundolo, Francesca M. Buffa, Remko Prevo, K Verschueren, Anderson J. Ryan, Valentine M. Macaulay, W. Gillies McKenna, Geoff S. Higgins	2017	22
8	The novel ATR inhibitor VE-821 increases sensitivity of pancreatic cancer cells to radiation and chemotherapy Cancer Biology & Therapy ·Remko Prevo, Emmanouil Fokas, Philip M. Reaper, Peter Charlton, John R. Pollard, W. Gillies McKenna, Ruth J. Muschel, Thomas Brunner	2012	191
9	Homologous recombination mediates S-phase-dependent radioresistance in cells deficient in DNA polymerase eta Carcinogenesis ·Nils H. Nicolay, Rebecca Carter, Stephanie B. Hatch, Niklas Schultz, Remko Prevo, W. Gillies McKenna, Thomas Helleday, Ricky A. Sharma	2012	10
10	NVP-BEZ235 and NVP-BGT226, dual phosphatidylinositol 3-kinase/mammalian target of rapamycin inhibitors, enhance tumor and endothelial cell radiosensitivity Radiation Oncology ·Emmanouil Fokas, Michio Yoshimura, Remko Prevo, Geoff S. Higgins, Wolfgang Hackl, Sauveur-Michel Maira, Eric J. Bernhard, Eva Salvatella, Ruth J. Muschel	2012	69
11	A Small Interfering RNA Screen of Genes Involved in DNA Repair Identifies Tumor-Specific Radiosensitization by POLQ Knockdown Cancer Research ·Geoff S. Higgins, Remko Prevo, Yin-Fai Lee, Thomas Helleday, Ruth J. Muschel, Steve L. Taylor, Michio Yoshimura, Ian D. Hickson, Eric J. Bernhard, W. Gillies McKenna	2010	100
12	Primary cerebellar nocardiosis and alveolar proteinosis Acta Neurologica Scandinavica ·Steven P. Lammers, E.N.H. Jansen, Remko Prevo, Michiel Eijsvogel	2009	18
13	Class I PI3 Kinase Inhibition by the Pyridinylfuranopyrimidine Inhibitor PI-103 Enhances Tumor Radiosensitivity Cancer Research ·Remko Prevo, Éric Deutsch, Oliver Sampson, Hasan Barboros, Keith A. Cengel, Jane Harper, Peter O’Neill, W. Gillies McKenna, Sonal Patel, Eric J. Bernhard	2008	106
14	Inflammation-induced Uptake and Degradation of the Lymphatic Endothelial Hyaluronan Receptor LYVE-1 Journal of Biological Chemistry ·Louise A. Johnson, Remko Prevo, Steven Clasper, David G. Jackson	2007	128
15	CCL21 Expression Pattern of Human Secondary Lymphoid Organ Stroma Is Conserved in Inflammatory Lesions with Lymphoid Neogenesis American Journal Of Pathology ·Antonio Manzo, Serena Bugatti, Roberto Caporali, Remko Prevo, David G. Jackson, Mariagrazia Uguccioni, Christopher D. Buckley, Carlomaurizio Montecucco, Costantino Pitzalis	2007	75
16	Rapid Plasma Membrane-Endosomal Trafficking of the Lymph Node Sinus and High Endothelial Venule Scavenger Receptor/Homing Receptor Stabilin-1 (Feel-1/Clever-1) Journal of Biological Chemistry ·Remko Prevo, Suneale Banerji, Jian Ni, David G. Jackson	2004	76
17	Dynamic Populations of Dendritic Cell-Specific ICAM-3 Grabbing Nonintegrin-Positive Immature Dendritic Cells and Liver/Lymph Node-Specific ICAM-3 Grabbing Nonintegrin-Positive Endothelial Cells in the Outer Zones of the Paracortex of Human Lymph Nodes American Journal Of Pathology ·Anneke Engering, Sandra J. van Vliet, Konnie M. Hebeda, David G. Jackson, Remko Prevo, Satwinder Singh, Teunis B. H. Geijtenbeek, J. Han van Krieken, Yvette van Kooyk	2004	75
18	Absence of lymphangiogenesis and intratumoural lymph vessels in human metastatic breast cancer The Journal of Pathology ·Salvador González Castro, Russell Leek, Alistair Robson, Suneale Banerji, Remko Prevo, Adrian L. Harris, David G. Jackson	2003	173
19	LYVE-1, the lymphatic system and tumor lymphangiogenesis Trends in Immunology ·David G. Jackson, Remko Prevo, Steven Clasper, Suneale Banerji	2001	278
20	Heparan Sulfate-modified CD44 Promotes Hepatocyte Growth Factor/Scatter Factor-induced Signal Transduction through the Receptor Tyrosine Kinase c-Met Journal of Biological Chemistry ·Robbert van der Voort, Taher E.I. Taher, 梁玉庆, Marcel Spaargaren, Remko Prevo, Lia Smit, Guido David, Guido R. Hartmann, Ermanno Gherardi, Steven T. Pals	1999	192

About Remko Prevo

Remko Prevo is a scholar working on Microbiology, Oncology, Cancer Research, Molecular Biology and Immunology and Allergy, having authored 34 papers that have together received 5.8k indexed citations. Recurring topics across this work include Lymphatic System and Diseases (12 papers), DNA Repair Mechanisms (8 papers), Angiogenesis and VEGF in Cancer (7 papers), PARP inhibition in cancer therapy (5 papers), Cancer, Hypoxia, and Metabolism (3 papers), Sympathectomy and Hyperhidrosis Treatments (3 papers), Cell death mechanisms and regulation (3 papers) and FOXO transcription factor regulation (3 papers). The work is most often cited by research in Oncology (4.1k citations), Molecular Biology (3.7k citations), Cancer Research (729 citations), Cell Biology (583 citations) and Immunology and Allergy (185 citations). Remko Prevo has collaborated with scholars based in United Kingdom, United States and Finland. Frequent co-authors include David G. Jackson, Suneale Banerji, Steven Clasper, Kari Alitalo, Michael Detmar, Lucia Riccardi, Kevin P. Claffey, Thomas Hawighorst, Mihaela Skobe and Lauren Janes. Their work appears in journals such as Journal of Biological Chemistry, Cell Death and Disease, British Journal of Cancer, Nature Medicine and Cancer Biology & Therapy.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact